Local targets for immune therapy to cancer: Tumor draining lymph nodes and tumor microenvironment
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Local targets for immune therapy to cancer: Tumor draining lymph nodes and tumor microenvironment
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 132, Issue 9, Pages 1971-1976
Publisher
Wiley
Online
2012-08-02
DOI
10.1002/ijc.27755
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting CpG Oligonucleotides to the Lymph Node by Nanoparticles Elicits Efficient Antitumoral Immunity
- (2014) C. Bourquin et al. JOURNAL OF IMMUNOLOGY
- Natural Innate and Adaptive Immunity to Cancer
- (2011) Matthew D. Vesely et al. Annual Review of Immunology
- Endogenous T Cell Responses to Antigens Expressed in Lung Adenocarcinomas Delay Malignant Tumor Progression
- (2011) Michel DuPage et al. CANCER CELL
- Local Activation of CD8 T Cells and Systemic Tumor Eradication without Toxicity via Slow Release and Local Delivery of Agonistic CD40 Antibody
- (2011) M. F. Fransen et al. CLINICAL CANCER RESEARCH
- CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
- (2011) G. L. Beatty et al. SCIENCE
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Accumulation of Foxp3+ T Regulatory Cells in Draining Lymph Nodes Correlates with Disease Progression and Immune Suppression in Colorectal Cancer Patients
- (2010) L. Deng et al. CLINICAL CANCER RESEARCH
- Immunosenescence and cancer
- (2010) Graham Pawelec et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Natural immunity to cancer in humans
- (2010) Gabriela Bindea et al. CURRENT OPINION IN IMMUNOLOGY
- Foxp3+ T Cells Induce Perforin-Dependent Dendritic Cell Death in Tumor-Draining Lymph Nodes
- (2010) Alexandre Boissonnas et al. IMMUNITY
- Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice
- (2010) Rupal Ramakrishnan et al. JOURNAL OF CLINICAL INVESTIGATION
- In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study
- (2010) Joshua D. Brody et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor masses support naive T cell infiltration, activation, and differentiation into effectors
- (2010) Elizabeth D. Thompson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Separate Roles for Antigen Recognition and Lymph Node Inflammation in CD8+ Memory T Cell Formation
- (2010) M. F. Fransen et al. JOURNAL OF IMMUNOLOGY
- Delivery of Immunostimulatory RNA Oligonucleotides by Gelatin Nanoparticles Triggers an Efficient Antitumoral Response
- (2010) Carole Bourquin et al. JOURNAL OF IMMUNOTHERAPY
- Suppressing an Anti-Inflammatory Cytokine Reveals a Strong Age-Dependent Survival Cost in Mice
- (2010) Virginia Belloni et al. PLoS One
- Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV Melanoma
- (2009) Howard L. Kaufman et al. ANNALS OF SURGICAL ONCOLOGY
- Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes
- (2009) M. D. Sharma et al. BLOOD
- Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonists
- (2009) K. S. Peggs et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma
- (2009) Neil N. Senzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
- (2009) S. Ostrand-Rosenberg et al. JOURNAL OF IMMUNOLOGY
- Route of Administration of the TLR9 Agonist CpG Critically Determines the Efficacy of Cancer Immunotherapy in Mice
- (2009) Stefan Nierkens et al. PLoS One
- Enhanced efficacy and reduced toxicity of multifactorial adjuvants compared with unitary adjuvants as cancer vaccines
- (2008) C. L. Ahonen et al. BLOOD
- Regulated Expression of a Tumor-Associated Antigen Reveals Multiple Levels of T-Cell Tolerance in a Mouse Model of Lung Cancer
- (2008) A. F. Cheung et al. CANCER RESEARCH
- Local Administration of PF-3512676 CpG-B Instigates Tumor-Specific CD8+ T-Cell Reactivity in Melanoma Patients
- (2008) B. G. Molenkamp et al. CLINICAL CANCER RESEARCH
- Cancer Immunotherapy by Dendritic Cells
- (2008) Cornelis J.M. Melief IMMUNITY
- Twelve immunotherapy drugs that could cure cancers
- (2008) Martin A. ‘Mac’ Cheever IMMUNOLOGICAL REVIEWS
- Deliberately provoking local inflammation drives tumors to become their own protective vaccine site
- (2008) Connie Jackaman et al. INTERNATIONAL IMMUNOLOGY
- In situ gelling hydrogels for pharmaceutical and biomedical applications
- (2008) Sophie R. Van Tomme et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Detection of melanoma micrometastases in sentinel nodes – The cons
- (2008) Johannes H.W. de Wilt et al. SURGICAL ONCOLOGY-OXFORD
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started